Report overview
The global Tumor Immunity Therapy market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market is estimated at $ million in 2024, while China is to reach $ million.
Immune Checkpoint Inhibitor segment will reach $ million by 2032, with a % CAGR in next six years.
The global key players of Tumor Immunity Therapy include Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., IMVAQ Therapeutics, Arch Oncology, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Tumor Immunity Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Tumor Immunity Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Immunity Therapy. This report contains market size and forecasts of Tumor Immunity Therapy in global, including the following market information:
Global Tumor Immunity Therapy market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Tumor Immunity Therapy companies in 2024 (%)
Total Market by Segment:
Global Tumor Immunity Therapy market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Tumor Immunity Therapy market segment percentages, by Type, 2024 (%)
Immune Checkpoint Inhibitor
Cytokine Immunotherapy
Cancer Vaccine
Car-t Cell Therapy
Others
Global Tumor Immunity Therapy market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Tumor Immunity Therapy market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Tumor Immunity Therapy market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Tumor Immunity Therapy market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Immunity Therapy revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Tumor Immunity Therapy revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
IMVAQ Therapeutics
Arch Oncology
Juno Therapeutics
Refuge
Lepu Biopharma
Genoimmune
TCR Cure
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tumor Immunity Therapy, market overview.
Chapter 2: Global Tumor Immunity Therapy market size in revenue.
Chapter 3: Detailed analysis of Tumor Immunity Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tumor Immunity Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
